Progress in Childhood Cancer: 50 Years of Research Collaboration, a Report From the Children's Oncology Group

Seminars in Oncology

Volumn 35, Issue 5, 2008, Pages 484-493

  O'Leary, Maura ^a   Krailo, Mark ^a   Anderson, James R ^a   Reaman, Gregory H ^a  

^a CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; AZASERINE; AZAURACIL; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DEXAMETHASONE; DOXORUBICIN; FLOXURIDINE; FLUOROURACIL; FOLIC ACID ANTAGONIST; LUCANTHONE; MERCAPTOPURINE; MERCAPTOPURINE RIBOSIDE; METHOTREXATE; MITOMYCIN C; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BRAIN TUMOR; CANCER DIAGNOSIS; CANCER RESEARCH; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CHILDHOOD CANCER; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; HEALTH CARE ORGANIZATION; HEPATOBLASTOMA; HUMAN; MOLECULAR GENETICS; NEPHROBLASTOMA; NEUROBLASTOMA; ONCOLOGY; OSTEOSARCOMA; PRIORITY JOURNAL; REMISSION; RHABDOMYOSARCOMA; SURVIVAL RATE;

CHILD; CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; PEDIATRICS; RESEARCH;

EID: 53149129878     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2008.07.008     Document Type: Article

References (66)

1. Children's Oncology Group. Internal documents.
2. Burchenal J.H., Lester R.A., Riley J.B., et al. Studies on the chemotherapy of leukemia. Cancer 1 (1948) 399-412
3. Farber S., Diamond L.K., Mercer R.D., et al. Temporary remissions in acute leukemia in children produced by folic acid antagonists, 4-aminopteroyl-glutamic acid (aminopterin). N Engl J Med 238 (1948) 787
4. Pearson O.H., and Eliel L.P. Use of adrenocorticotropic hormone (ACTH) and cortisone in lymphomas and leukemias. JAMA 144 (1950) 1349
5. Burchenal J.H., Murphy M.L., Ellison R.R., et al. Clinical evaluation of a new anti-metabolite, 6-mercapto purine in the treatment of leukemia and allied diseases. Blood 8 (1953) 965-999
6. Heyn R.M., Brubaker C.A., Burchenal J.H., et al. The comparison of 6-mercaptopurine with the combination of 6-mercaptopurine and azaserine in the treatment of acute leukemia in children: results of a cooperative study. Blood 15 (1960) 350-359
7. Sitarz A., Heyn R., Murphy M.L., et al. Triple drug therapy with actinomycin-D (NSC 3053), chlorambucil (NSC 3088) and methotrexate (NSC 740) in metastatic solid tumors in children. Cancer Chemother Rep 45 (1965) 45
8. Wolff JA, Brubaker CA, Murphy ML, et al. Maintenance of prednisone induced remissions of acute childhood leukemia by thiopurines.
9. Krivit W., Brubaker C., Hartmann J.R., et al. Cyclic vs. sequential use of chemotherapeutic agents in acute leukemia of childhood. [abstract] (1966) Proceedings of the American Association of Cancer Research 57th Annual Meeting, Denver, CO
10. Leikin S.L., Brubaker C., Hartmann J.R., et al. Varying Prednisone dosage in remission induction of previously untreated childhood leukemia. Cancer 21 (1968) 346-351
11. Wolff J.A., Krivit W., Newton W.A., et al. Single versus multiple dose dactinomycin therapy of Wilms' tumor. N Engl J Med 279 (1968) 290-294
12. D'Angio G.J., Evans A.E., Breslow N., et al. The treatment of Wilms' tumor: results of the National Wilms' Tumor Study. Cancer 38 (1976) 633-646
13. D'Angio G.J., Evans A., Breslow N., et al. The treatment of Wilms' tumor: results of the second National Wilms' Tumor Study. Cancer 47 (1981) 2302
14. D'Angio G.J., Breslow N., Beckwith J.B., et al. The treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer 64 (1989) 349-360
15. Green D., Breslow N., Beckwith J., et al. The effect of duration of treatment on outcome and cost of the treatment for Wilms' Tumor. A report from the National Wilms' Tumor Study Group. J Clin Oncol 16 (1998) 3744-3751
16. Green D., Breslow N., Beckwith J., et al. A comparison between single dose and divided dose administration of dactinomycin and doxorubicin. A report from the National Wilms' Tumor Study Group. J Clin Oncol 16 (1998) 237-244
17. Evans A.E., Nrokool P., Evan I., et al. Late effects of treatment for Wilms' tumor. A report from the National Wilms' Tumor Study Group. Cancer 67 (1991) 331-336
18. Grundy P.E., Breslow N.E., Li S., et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 23 (2005) 7312-7321
19. Beckwith J.B., and Palmer N. Histopathology and prognosis of Wilms' tumor: results of the National Wilms' Tumor Study. Cancer 41 (1978) 1937
20. Pierce M.I., Borges W.H., Heyn R.M., et al. Epidemiologic factors and survival experience in 1770 children with acute leukemia. Cancer 23 (1969) 1296-1304
21. Nesbit M., Chard R., Evans A., et al. Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia. Am J Pediatr Hematol Oncol 1 (1979) 9-13
22. Heyn R., and Holland R. Treatment of rhabdomyosarcoma in children. [abstract]. Proc Am Assoc Cancer Res 2 (1970) 36
23. Mauer H.M., Beltangady M., Gehan E.A., et al. The Intergroup Rhabdomyosarcoma Study-I: a final report. Cancer 61 (1988) 209-220
24. Maurer H.M., Gehan E.A., Beltangady M., et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer 71 (1993) 1904-1922
25. Crist W.M., Garnsey L., Beltangady M.S., et al. Prognosis in children with rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Studies I and II. Intergroup Rhabdomyosarcoma Committee. J Clin Oncol 8 (1990) 443-452
26. Crist W., Gehan E.A., Ragab A.H., et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13 (1995) 610-630
27. Crist W.M., Anderson J.R., Meza J.L., et al. Intergroup Rhabdomyosarcoma Study-IV: results for patients with nonmetastatic disease. J Clin Oncol 19 (2001) 3091-3102
28. Donaldson S.S., Meza J., Breneman J.C., et al. Results from the IRS-IV randomized trial of hyper fractionated radiotherapy in children with rhabdomyosarcoma-a report from the IRSG. Int J Radiat Oncol Biol Phys 51 (2001) 718-728
29. Nesbit Jr. M.E., Gehan E.A., Burgert Jr. E.O., et al. Multimodal therapy for the management of primary, non-metastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup Study. J Clin Oncol 8 (1990) 1664-1674
30. Razek A., Perez C.A., Tefft M., et al. Intergroup Ewing's Sarcoma Study: local control related to radiation dose, volume and site of primary lesion in Ewing's sarcoma. Cancer 46 (1980) 516-521
31. Perez C.A., Tefft M., Nesbit Jr. M.E., et al. Radiation therapy in the multimodal management of Ewing's sarcoma of bone: report of the Intergroup Ewing's Sarcoma Study. Natl Cancer Inst Monogr (1981) 263-271
32. Burgert Jr. E.O., Nesbit M.E., Garnsey L.A., et al. Multimodal therapy for the management of nonpelvic, localized Ewing's Sarcoma of bone: intergroup study IESS-II. J Clin Oncol 8 (1990) 1514-1524
33. Brodeur G.M., Seeger R.C., Barrett A., et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6 (1988) 1874-1881
34. Camitta B., Leventhal B., Lauer S., et al. Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol 7 (1989) 1539-1544
35. Crist W., Carroll A., Shuster J., et al. Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood 76 (1990) 489-494
36. Jackson J.F., Boyett J., Pullen J., et al. Favorable prognosis associated with hyperdiploidy in children with acute lymphocytic leukemia correlates with extra chromosome 6. A Pediatric Oncology Group study. Cancer 66 (1990) 1183-1189
37. Harris M.B., Shuster J.J., Carroll A., et al. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study. Blood (1992) 3316-3324
38. Ravindranath Y., Abella E., Krischer J.P., et al. Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML study 8498. Blood 80 (1992) 2210-2214
39. Link M., Goorin A.M., Miser A.W., et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314 (1986) 1600-1602
40. Duffner P.K., Horowitz M.E., Krischer J.P., et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328 (1993) 1725-1731
41. Smith M., Arthur D., Camitta B., et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 14 (1996) 18-24
42. Grier H.E., Krailo M.D., Tarbell N.J., Link M.P., et al. Addition of ifosfamide and etoposide to standard therapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348 (2003) 694-701
43. Ortega J.A., Krailo M.D., Haas J.E., et al. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin: a report from the Children's Cancer Study Group. J Clin Oncol 9 (1991) 2167-2176
44. Douglass E.C., Reynolds M., Finegold M., et al. Cisplatin, vincristine and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study. J Clin Oncol 11 (1993) 96-99
45. Ortega J.A., Douglass E.C., Feusner J.H., et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 18 (2000) 2665-2675
46. Nesbit M.E., Sather H., Robison L.L., et al. Sanctuary therapy: a randomized trial of 724 children with previously untreated acute lymphoblastic leukemia: a report from Children's Cancer Study Group. Cancer Res 42 (1982) 674-680
47. Nesbit Jr. M.E., Sather H.N., Robison L.L., et al. Randomized study of 3 years versus 5 years of chemotherapy in childhood acute lymphoblastic leukemia. J Clin Oncol 1 (1983) 308-316
48. Gaynon P.S., Trigg M.E., Heerema N.A., et al. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995. Leukemia 14 (2000) 2223-2233
49. Bostrom B.C., Sensel M.G., Sather H.N., et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 101 (2003) 3809-3817
50. Gaynon P.S., Bleyer W.A., Steinherz P.G., et al. Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features. Med Pediatr Oncol 18 (1990) 273-279
51. Evans A.E., Jenkin R.D., Sposto R., et al. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 72 (1990) 572-582
52. Packer R.J., Goldwein J., Nicholson H.S., et al. Treatment of children with medulloblastoma with reduced-dose craniospinal radiation and adjuvant chemotherapy: a Children's Cancer Group study. J Clin Oncol 17 (1999) 2127-2136
53. Patte C., Auperin A., Gerrard M., Michon J., et al. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood 109 (2007) 2773-2780
54. Cairo M.S., Gerrard M., Sposto R., et al. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood 109 (2007) 2736-2743
55. Matthay K.K., Villablanca J.G., Seeger R.C., et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 341 (1999) 1165-1173
56. Matthay K.K., Sather H.N., Seeger R.C., et al. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 7 (1989) 236-244
57. Nesbit M., Buckley L., Lampkin B., et al. Comparison of allogeneic bone marrow transplantation (BMT) with maintenance chemotherapy in previously untreated childhood acute nonlymphocytic leukemia (ANLL). [abstract]. Proc Am Soc Clin Oncol 6 (1987) 163
58. Woods W.G., Ruymann F.B., Lampkin B.C., et al. The role of timing of high-dose cytosine arabinoside intensification and of maintenance therapy in the treatment of children with acute nonlymphocytic leukemia. Cancer 66 (1990) 1106-1113
59. Hilden J.M., Dinndorf P.A., Meerbaum S.O., et al. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. Blood 108 (2006) 441-451
60. Neglia J.P., Meadows A.T., Robison L.L., et al. Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 325 (1991) 1330-1336
61. Bleyer W.E., Fallavollita J., Robison L., et al. Influence of age, sex, and concurrent intrathecal methotrexate therapy on intellectual function after cranial irradiation during childhood: a report from the Children's Cancer Study Group. Pediatr Hematol Oncol 7 (1990) 329-338
62. Borowitz M., Devidas M., Bowman W.P., et al. Prognostic significance of minimal residual disease (MRD) in childhood precursor ALL and its relation to other risk factors. A Children's Oncology Group (COG). Blood 108 (2006) 219
63. Bhojwani D., Kang H., Moskowitz N.P., et al. Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. Blood 108 (2006) 711-717
64. Reaman G.H., and Haase G.M. Quality of life research in childhood cancer. The time is now. Cancer 78 (1996) 1330-1332
65. Avramis V.I., Sencer S., Periclou A.P., et al. A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study. Blood 99 (2002) 1986-1994
66. Hammond G.D., Nixon D.W., Nachman J.B., et al. American Cancer Society Workshop on Adolescents and Young Adults with Cancer. Workgroup #4: Clinical research implications. Cancer 71 (1993) 2423